Eczema trials recruiting in North Carolina

All Eczema trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Wilmington
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07690371 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · North Carolina: Wilmington
• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
  NCT06389136 · Phase: Phase 3 · Ages: 18 Years to 63 Years · Sex: All (male and female) · North Carolina: Huntersville
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07037901 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · North Carolina: Charlotte
• An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
  NCT06627335 · Phase: Not specified · Ages: 14 Years and older · Sex: Female · North Carolina: Morrisville
• An Observational Study of Patients With Dermatologic Disease
  NCT07748169 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · North Carolina: Winston-Salem
• Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07298395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Wilmington
• Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
  NCT06259669 · Phase: Not specified · Ages: 15 Years to 50 Years · Sex: Female · North Carolina: Morrisville
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · North Carolina: Huntersville, Winston-Salem
• Topical Treatment for Atopic Dermatitis
  NCT06244212 · Phase: Not applicable (e.g. observational or device study) · Ages: 9 Years and older · Sex: All (male and female) · North Carolina: Winston-Salem